Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 19.11 -0.68 (3.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.79 | 52 Week High | $12.48 | |||
| Open | $19.42 | 52 Week Low | $1.60 | |||
| Day High | $19.59 | P/E | N/A | |||
| Day Low | $18.71 | EPS | $-6.33 | |||
| Volume | 1,874,210 | |||||
